Order Hymovis® (German) for Clinics

Hymovis® (German) is a sterile hyaluronan viscosupplement supplied as prefilled syringes for intra-articular administration by trained healthcare professionals. Licensed clinics can order Hymovis® (German) in the 24mg/3mL presentation with two 3mL prefilled syringes for knee osteoarthritis injection workflows. The ready-to-use syringe format supports treatment-room setup, lot traceability, and standardized handling for orthopedic, rheumatology, and sports medicine services.

Med Wholesale Supplies serves licensed clinics and healthcare professionals with brand-name medical products sourced through vetted distributors and verified supply channels. For facilities managing recurring viscosupplementation days, this German-labeled pack can help align purchasing, documentation, and procedure-room preparation across approved staff roles.

Hymovis® (German) Price, Pack Details, and Clinic Ordering

Clinic accounts can view the current Hymovis® (German) price after signing in. Pricing may depend on active account terms, ordered quantity, and the pack configuration selected during checkout. Use the product name, German-labeled presentation, and SKU 89042 when matching procurement records to internal purchasing approvals.

This pack contains two prefilled syringes, each with a 3mL fill, at the supplied concentration of Hymovis 24mg/3mL. The format is intended for professional intra-articular use, and each unit is single use. Lot number and expiration information on the carton support receiving checks, inventory rotation, and clinical documentation.

Facilities ordering for multiple sites should keep the purchase record aligned with their formulary description. If your program specifies Hymovis prefilled syringes, the 2-syringe format may simplify reorder counts and procedure-day planning. For category-level purchasing, the orthopedic injections assortment can support broader joint-care inventory review.

What Hymovis® Is Used For in Professional Practice

Hymovis® is a hyaluronan-based viscosupplement used for intra-articular knee injection workflows in osteoarthritis care. Viscosupplementation means supplementing the joint’s synovial fluid with a gel-like material designed to improve lubrication and shock-absorbing properties. In practice, clinics use products in this class when the care plan calls for a mechanical supplement inside the knee joint.

The product is administered by qualified professionals using aseptic technique. It is not a self-administered product, and patient selection belongs with the treating clinician. Orthopedics, rheumatology, sports medicine, and ambulatory procedure teams often build these injections into structured visit pathways that include consent, sterile setup, documentation, observation, and follow-up instructions.

For teams building a knee osteoarthritis injection program, the Hymovis injection article provides additional background on the product’s role in joint discomfort management. Clinics evaluating class fit can also browse the rheumatology category for adjacent products used in musculoskeletal care.

Active Ingredient and How the Injection Works

The active component is highly purified hyaluronan, also referred to as sodium hyaluronate. Hyaluronan is a naturally occurring substance found in synovial fluid, where it contributes to viscosity, lubrication, and cushioning during movement. In an osteoarthritic knee, synovial fluid properties may be altered, so a viscosupplement is used as a mechanical support rather than a disease-curing medication.

Hymovis® is supplied as a sterile, viscoelastic solution. Its gel-like profile supports procedural consistency for intra-articular administration. The prefilled format reduces on-bench preparation, limits extra transfer steps, and helps maintain an aseptic workflow when used according to the manufacturer’s instructions for use.

Teams sometimes ask whether Hymovis® has another name. In purchasing and clinical documentation, the product may be described by brand name, by its hyaluronan or sodium hyaluronate active component, or more generally as a hyaluronic acid viscosupplement. Use the exact brand and pack description on internal records to avoid confusion with other hyaluronic acid injections.

Key Features for Treatment-Room Workflow

• Sterile prefilled syringes: Ready-to-use presentation supports aseptic setup and reduces preparation steps.
• Two-syringe pack: The carton contains two 3mL prefilled syringes for planned clinic inventory use.
• 24mg/3mL strength: The supplied concentration supports standardized documentation and tray preparation.
• Single-use design: Each syringe is intended for one patient and one procedure only.
• German-labeled pack: Useful when clinic teams require this labeled presentation for purchasing alignment.
• Traceability details: Lot and expiration information support inventory audits and procedure records.
• Professional administration: Intended for intra-articular use by trained healthcare professionals.

Quick tip: Keep the carton description, lot number, and expiration date visible during receiving so purchasing and clinical teams can reconcile stock efficiently.

Professional Administration and Scheduling Considerations

A Hymovis knee injection is performed into the joint space by a licensed professional using aseptic technique. Facilities may use imaging guidance, procedure trays, sterile skin preparation, needles selected by clinical policy, and post-procedure observation according to local protocols. The syringe itself should be handled as a sterile, single-use product and discarded after administration.

Clinics often coordinate viscosupplementation visits with rehabilitation planning, bracing discussions, or follow-up assessment. The treatment schedule should follow the official product labeling and the treating clinician’s protocol. Purchasing teams should avoid substituting another hyaluronic acid injection without clinical review because syringe volume, concentration, labeling, and administration schedule can differ across products.

If your team is comparing other hyaluronic acid injections, the article on Hyalgan and other hyaluronic acid injections discusses class-level selection factors. For another professional-use viscosupplement product, Supartz IT may be relevant to clinic formulary review.

Storage, Handling, and Receiving Checks

Store and handle Hymovis® according to the manufacturer’s instructions included with the pack. Receiving staff should inspect the carton for integrity, verify the product name and German-labeled presentation, capture the lot number, and confirm the expiration date before placing stock into inventory. Do not use a syringe if the sterile barrier appears compromised or if the product does not match the facility’s purchase order.

Because viscosupplement injections are used in procedural settings, inventory control should connect purchasing records with treatment-room documentation. This helps support charge capture, adverse event review, product recall response, and reorder planning. Grouping syringes with compatible procedure supplies in a controlled inventory system can reduce pick errors and shorten room turnover.

Med Wholesale Supplies supports clinic procurement with reliable US logistics and temperature-controlled handling when required and tracked US delivery. Product teams should still follow the storage conditions on the official pack because shipping safeguards do not replace facility-level handling requirements.

Safety, Side Effects, and Precautions

Hymovis® should be used only by trained healthcare professionals familiar with intra-articular injection technique and the official instructions for use. Before administration, the clinical team should review the patient’s history, knee status, allergy concerns, and any precautions listed by the manufacturer. Use should be avoided when contraindications in the official labeling apply.

Commonly observed events after intra-articular hyaluronan administration can include injection-site pain, swelling, warmth, stiffness, bruising, or localized discomfort. These events are often transient, but the clinic should provide clear instructions for post-procedure monitoring. Less common hypersensitivity-type reactions may include rash, itching, or hives. Severe reactions, signs of infection, or unexpected joint symptoms warrant prompt medical assessment under the facility’s protocol.

Procedure teams should maintain sterile technique, avoid use through compromised skin, and document any adverse events according to policy. Product substitution should be reviewed clinically because other viscosupplements may differ in formulation, pack size, volume, dosing schedule, and labeling. For broader osteoarthritis injection context, the discussion of Synvisc in severe osteoarthritis may help teams frame patient questions without replacing product-specific labeling.

Documentation and Inventory Planning

Hymovis® (German) fits clinics that need clear lot tracking and predictable procedure-room setup. The two-syringe carton supports inventory planning for scheduled injection days, bilateral scheduling review when clinically appropriate, or consecutive patient appointments. Staff should keep product cartons organized by expiration date and rotate inventory using the facility’s standard method.

Document the product name, syringe details, lot number, expiration date, administration site, clinician, and any immediate post-procedure observations according to facility policy. Electronic health record templates can reduce variation across providers, while barcode or manual reconciliation can connect clinical documentation with purchasing and charge workflows.

Facilities that stock multiple procedural products may benefit from grouping viscosupplements, injection supplies, and other treatment-room materials under a single category review. The medical devices category can support broader procedure-area purchasing, while the Hymovis brand category can help teams stay aligned with related brand-specific inventory.

How Hymovis® Compares With Nearby Viscosupplement Options

Hymovis® belongs to the hyaluronic acid viscosupplement class, but clinics should not treat all products in this class as interchangeable without review. Formulation, molecular characteristics, syringe volume, pack count, recommended administration schedule, and market labeling can vary. Those differences matter for procedure preparation, patient counseling, purchasing records, and staff training.

Monovisc is another hyaluronic acid injection used in knee osteoarthritis care, but it is a separate brand with its own labeling and administration instructions. When clinicians ask what a Monovisc injection is for, the practical answer is that it is also a viscosupplement used for osteoarthritis-related knee pain in appropriate patients. It should not be substituted for Hymovis® solely because both are hyaluronic acid products.

Purchasing teams should involve clinical leadership before changing a formulary item. Review the product’s official instructions, pack format, concentration, storage requirements, and procedure schedule. A structured comparison prevents mismatches between what was ordered, what staff were trained to use, and what appears in the treatment protocol.

Authoritative Sources

• Hymovis package insert and professional labeling
• Manufacturer product information
• Peer-reviewed report on a Hymovis viscoelastic hydrogel study

Ready to proceed? Sign in to view current pack pricing, confirm the needed quantity, and place a clinic order for Hymovis® (German) with the product details required for purchasing records.

This content is for informational purposes only and is not a substitute for professional medical advice.